News

Seven people in a group sitting together

New in vivo gene editing biotech blossoms from CRISPR pioneer Jennifer Doudna’s lab with $82M

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed with $82 million in funding and a dual-vector approach that the company hopes can enable permanent genome editing with a single dose. The funding total includes a $65 million series A that was led by Third Rock Ventures, with RA Capital Management, Yosemite and Sozo Ventures joining the financing bouquet.

Latest news219

Umaro's bacon made from seaweed

Umaro Is Turning Ocean-Farmed Seaweed Into Imitation Bacon

“I knew biofuel was not commercially viable near term so focused my efforts identifying a new commercial opportunity in seaweed,” says CEO Beth Zotter. Read post
A cartoon of a scientist at a lab bench with a microscope and test tubes

CFF’s ‘Golden Ticket’ Competition Will Support Early Gene Research

“As part of our relentless pursuit of a cure, we are dedicated to investing in early stage science. We know that to make progress toward our bold mission to cure CF, we need to attract bold, like-minded researchers,” said Martin Mense, PhD, senior vice president of drug discovery and director of the Cystic Fibrosis Foundation Therapeutics Lab Read post
Decorative graphic with wording "Golden Ticket Competition"

Bakar Labs and the Cystic Fibrosis Foundation Support Entrepreneurs to Develop New Genetic Therapies for CF

Up to 3 selected companies will win "Golden Tickets" for lab space at Bakar Labs, and access to the extensive resources of the CF Foundation, including scientific experts and advice, lab/research tools and techniques, an extensive patient registry, clinical trial design support, and a Therapeutics Development Network of over 90 clinical trial sites in the US. Read post
Aerial view of BBH

Bakar BioEnginuity Hub Raises the Bar for Urban Adaptive Reuse Projects

“The original building structural design is kind of a house of cards,” says Allen Nudel, director of business strategy at Forell/Elsesser who led the structural team. “It’s an awe-inspiring and beautiful icon of innovation, and one of the most architecturally complicated structures in the Bay Area—maybe in the entire western United States. It was by far the most difficult seismic retrofit we’ve ever done.” Read post
An interior view of BBH's skylights

A First Look Inside UC Berkeley’s Bakar BioEnginuity Hub

“We always intended Bakar Labs to have a ‘double bottom line,’ a responsibility to select and support startups that have a strong chance of market success and are developing solutions to make the world a better place,” said Regis Kelly, director of Bakar Labs and QB3 executive director. Read post